Luxembourg: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Luxembourg

In 2022, the Luxembourg market for other medicaments for therapeutic or prophylactic uses decreased by X% to $X, falling for the fourth consecutive year after four years of growth. Over the period under review, consumption faced a abrupt decrease. Consumption of peaked at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Luxembourg

In value terms, production of other medicaments for therapeutic or prophylactic uses rose markedly to $X in 2022 estimated in export price. In general, the total production indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The growth pace was the most rapid in 2015 when the production volume increased by X%. Over the period under review, production of attained the maximum level at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Luxembourg

Exports of other medicaments for therapeutic or prophylactic uses from Luxembourg soared to X kg in 2022, increasing by X% against the year before. In general, exports, however, saw a deep downturn. The most prominent rate of growth was recorded in 2013 when exports increased by X%. Over the period under review, the exports of reached the peak figure at X tons in 2020; however, from 2021 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses shrank dramatically to $X in 2022. Over the period under review, exports, however, saw a precipitous contraction. The pace of growth was the most pronounced in 2013 when exports increased by X% against the previous year. The exports peaked at $X in 2020; however, from 2021 to 2022, the exports failed to regain momentum.

Exports by Country

Belgium (X kg) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Luxembourg, with a approx. X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Belgium totaled X%.

From 2012 to 2022, the average annual growth rate of value to Belgium totaled X%.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, reducing by X% against the previous year. In general, the export price showed a precipitous slump. The pace of growth appeared the most rapid in 2016 when the average export price increased by X%. The export price peaked at $X per ton in 2018; however, from 2019 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Belgium.

From 2012 to 2022, the rate of growth in terms of prices for France amounted to X% per year.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Luxembourg

After three years of growth, supplies from abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons in 2022. Over the period under review, imports, however, recorded a prominent increase. The most prominent rate of growth was recorded in 2021 with an increase of X%. As a result, imports reached the peak of X tons, and then dropped notably in the following year.

In value terms, imports of other medicaments for therapeutic or prophylactic uses shrank remarkably to $X in 2022. In general, imports, however, posted resilient growth. The growth pace was the most rapid in 2021 when imports increased by X%. As a result, imports attained the peak of $X, and then reduced markedly in the following year.

Imports by Country

In 2022, Belgium (X tons) was the main supplier of other medicaments for therapeutic or prophylactic uses to Luxembourg, accounting for a X% share of total imports. It was followed by Germany (X kg), with a X% share of total imports. The third position in this ranking was taken by France (X kg), with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Belgium stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and France (X% per year).

In value terms, Belgium ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Luxembourg, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with a X% share of total imports. It was followed by France, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Belgium amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and France (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, reducing by X% against the previous year. In general, the import price, however, saw a prominent expansion. The growth pace was the most rapid in 2013 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2016; however, from 2017 to 2022, import prices remained at a lower figure.

Average prices varied somewhat amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Germany ($X per ton) and France ($X per ton), while the price for Belgium ($X per ton) and the United States ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :